Mustafa Hayder Matouk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mustafa Hayder Matouk has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Abdul Rani Samsudin
College of Dental Medicine, University of Sharjah, United Arab Emirates
1 shared publication - Aghila Rani Koippallil Gopalakrishnan
Research Institute for Medical and Health Sciences University of Sharjah Sharjah UAE
1 shared publication - Asmaa Anwar Ismail
Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, UAE, sharjah.ac.ae
1 shared publication - Sausan Al Kawas
Department of Oral & Craniofacial Health Sciences, College of Dental Medicine University of Sharjah Sharjah UAE
1 shared publication - Waad Kheder
Department of Restorative Dentistry, College of Dental Medicine University of Sharjah Sharjah UAE
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in International Journal of Dentistry
- Vol. 2026 (1) , 6486868
A Comparative Study on the Influence of Zirconia and Titanium Nanoparticles on the Functionality of Osteocytes In Vitro
Introduction and Aim: The aim of this study was to compare the influence of zirconia dioxide nanoparticles (ZrO 2 ‐NPs) and titanium dioxide nanoparticles (TiO 2 ‐NPs) on the functionality of osteocytes in vitro. Methods: MLO‐Y4 osteocytic cells were treated with varying concentrations of ZrO 2 ‐NPs or TiO 2 ‐NPs for viability studies. Apoptosis assays following treatment with 100 and 500 µg/mL of ZrO 2 ‐NPs or TiO 2 ‐NPs for 72 h were performed. Sclerostin (SOST) levels were assessed at 24 and 72 h, while receptor activator of nuclear factor kappa‐B ligand (RANKL) and osteoprotegerin (OPG) were measured at 72 h by ELISA and real‐time PCR analysis. Results: Viability assays revealed a dose‐dependent cytotoxicity for both types of nanoparticles, with TiO 2 ‐NPs reducing cell viability at 100 µg/mL within 24 h, while ZrO 2 ‐NPs promoted proliferation at lower concentrations but showed similar cytotoxicity at higher doses. Apoptosis and necrosis assays revealed a dose‐dependent cytotoxic response, with TiO 2 ‐NPs inducing significant cell death at 100 µg/mL, while ZrO 2 NPs showed minimal effects at the same concentration; at 500 µg/mL, both nanoparticles markedly increased apoptosis, with TiO 2 ‐NPs eliciting higher apoptosis. SOST gene expression and SOST release were significantly enhanced following exposure to both ZrO 2 ‐NPs and TiO 2 ‐NPs, with TiO 2 ‐NPs inducing significantly higher levels. TiO 2 ‐NPs upregulated RANKL while downregulating OPG both at the gene and protein levels. Although ZrO 2 ‐NPs exhibited a similar trend, their impact on SOST expression, RANKL, and OPG release was notably lower, suggesting a potentially less disruptive impact on bone remodeling. Conclusion: The findings offer valuable insights into the osteocyte‐mediated effects of implant‐related nanoparticles. ZrO 2 ‐NPs are a less disruptive alternative to TiO 2 ‐NPs for bone implants, offering insights into osteocyte‐mediated remodeling and guiding biomaterial selection for implant longevity.
- 1 January 2026
- Published by Wiley in International Journal of Dentistry
- Vol. 2026 (1) , 6486868
Open AccessA Comparative Study on the Influence of Zirconia and Titanium Nanoparticles on the Functionality of Osteocytes In Vitro
Introduction and Aim: The aim of this study was to compare the influence of zirconia dioxide nanoparticles (ZrO 2 ‐NPs) and titanium dioxide nanoparticles (TiO 2 ‐NPs) on the functionality of osteocytes in vitro. Methods: MLO‐Y4 osteocytic cells were treated with varying concentrations of ZrO 2 ‐NPs or TiO 2 ‐NPs for viability studies. Apoptosis assays following treatment with 100 and 500 µg/mL of ZrO 2 ‐NPs or TiO 2 ‐NPs for 72 h were performed. Sclerostin (SOST) levels were assessed at 24 and 72 h, while receptor activator of nuclear factor kappa‐B ligand (RANKL) and osteoprotegerin (OPG) were measured at 72 h by ELISA and real‐time PCR analysis. Results: Viability assays revealed a dose‐dependent cytotoxicity for both types of nanoparticles, with TiO 2 ‐NPs reducing cell viability at 100 µg/mL within 24 h, while ZrO 2 ‐NPs promoted proliferation at lower concentrations but showed similar cytotoxicity at higher doses. Apoptosis and necrosis assays revealed a dose‐dependent cytotoxic response, with TiO 2 ‐NPs inducing significant cell death at 100 µg/mL, while ZrO 2 NPs showed minimal effects at the same concentration; at 500 µg/mL, both nanoparticles markedly increased apoptosis, with TiO 2 ‐NPs eliciting higher apoptosis. SOST gene expression and SOST release were significantly enhanced following exposure to both ZrO 2 ‐NPs and TiO 2 ‐NPs, with TiO 2 ‐NPs inducing significantly higher levels. TiO 2 ‐NPs upregulated RANKL while downregulating OPG both at the gene and protein levels. Although ZrO 2 ‐NPs exhibited a similar trend, their impact on SOST expression, RANKL, and OPG release was notably lower, suggesting a potentially less disruptive impact on bone remodeling. Conclusion: The findings offer valuable insights into the osteocyte‐mediated effects of implant‐related nanoparticles. ZrO 2 ‐NPs are a less disruptive alternative to TiO 2 ‐NPs for bone implants, offering insights into osteocyte‐mediated remodeling and guiding biomaterial selection for implant longevity.